Ellington Financial Inc. Investing Cash Flow increased by 0.4% to -$1.91B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 200.6%, from -$633.77M to -$1.91B. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 19.0% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$288.83M | -$342.98M | -$803.16M | -$592.46M | -$716.67M | -$276.73M | -$166.83M | -$18.73M | -$116.54M | $13.73M | $296.44M | $392.97M | $76.29M | -$576.16M | -$621.36M | -$633.77M | -$495.73M | -$1.02B | -$1.91B | -$1.91B |
| QoQ Change | — | -18.7% | -134.2% | +26.2% | -21.0% | +61.4% | +39.7% | +88.8% | -522.3% | +111.8% | >999% | +32.6% | -80.6% | -855.2% | -7.8% | -2.0% | +21.8% | -106.3% | -87.1% | +0.4% |
| YoY Change | — | — | — | — | -148.1% | +19.3% | +79.2% | +96.8% | +83.7% | +105.0% | +277.7% | >999% | +165.5% | <-999% | -309.6% | -261.3% | -749.8% | -77.5% | -208.0% | -200.6% |